205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.06%
Revenue growth at 50-75% of INTC's 2.76%. Martin Whitman would worry about competitiveness or product relevance.
4.38%
Gross profit growth at 50-75% of INTC's 8.68%. Martin Whitman would question if cost structure or brand is lagging.
10.11%
EBIT growth similar to INTC's 10.61%. Walter Schloss might infer both firms share similar operational efficiencies.
9.21%
Operating income growth at 75-90% of INTC's 10.61%. Bill Ackman would demand a plan to enhance operating leverage.
7.23%
Net income growth 1.25-1.5x INTC's 5.16%. Bruce Berkowitz would see if strategic cost cutting or product mix explains this difference.
6.98%
EPS growth similar to INTC's 6.82%. Walter Schloss would assume both have parallel share structures and profit trends.
7.94%
Diluted EPS growth 1.25-1.5x INTC's 5.75%. Bruce Berkowitz would verify if strategic moves (e.g., targeted acquisitions, cost cuts) explain the edge.
-0.21%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.31%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-0.06%
Dividend reduction while INTC stands at 0.58%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
62.24%
OCF growth 1.25-1.5x INTC's 52.99%. Bruce Berkowitz would see if superior pricing or efficient operations explain the gap.
76.64%
FCF growth 50-75% of INTC's 146.21%. Martin Whitman would see if structural disadvantages exist in generating free cash.
101.87%
10Y revenue/share CAGR at 50-75% of INTC's 157.69%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
27.36%
5Y revenue/share CAGR at 75-90% of INTC's 33.09%. Bill Ackman would encourage strategies to match competitor’s pace.
20.00%
3Y revenue/share CAGR at 50-75% of INTC's 29.14%. Martin Whitman would question if the firm lags behind competitor innovations.
336.00%
10Y OCF/share CAGR above 1.5x INTC's 180.88%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
164.88%
5Y OCF/share CAGR above 1.5x INTC's 55.18%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
79.90%
3Y OCF/share CAGR at 50-75% of INTC's 108.94%. Martin Whitman would suspect weaker recent execution or product competitiveness.
578.69%
Below 50% of INTC's 1415.44%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
118.39%
5Y net income/share CAGR above 1.5x INTC's 66.70%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
70.62%
Below 50% of INTC's 232.71%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
24.55%
Below 50% of INTC's 140.46%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-7.32%
Negative 5Y equity/share growth while INTC is at 41.09%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-8.78%
Negative 3Y equity/share growth while INTC is at 29.32%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
602.36%
10Y dividend/share CAGR above 1.5x INTC's 125.95%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
155.50%
5Y dividend/share CAGR above 1.5x INTC's 40.06%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
102.39%
3Y dividend/share CAGR above 1.5x INTC's 21.43%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-1.46%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-2.44%
Inventory is declining while INTC stands at 11.99%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-0.34%
Negative asset growth while INTC invests at 1.00%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-0.17%
We have a declining book value while INTC shows 2.34%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
0.10%
Debt shrinking faster vs. INTC's 1.15%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
0.26%
R&D dropping or stable vs. INTC's 3.18%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
1.45%
SG&A declining or stable vs. INTC's 3.65%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.